73015-46-0

Upstream product

• 7217-59-6 2-Methoxybenzenethiol 
• 91901-31-4 (2-methoxyphenyl)(4-nitrophenyl)sulfane 
• 350-46-9 4-Fluoronitrobenzene 
• 73015-47-1 (2-methoxyphenyl)(4-nitrophenyl)sulfane 

Downstream Products

• 1374007-10-9 N-(4-((2-hydroxyphenyl)sulfonyl)phenyl)-1-methyl-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide 
• 1374007-11-0 2-((4-(1-methyl-3-(trifluoromethyl)-1H-pyrazole-5-carboxamido)phenyl)sulfonyl)phenyl acetate 
• 1374007-09-6 N-(4-((2-methoxyphenyl)sulfonyl)phenyl)-1-methyl-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide 

Relevant academic research and scientific papers

Non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase: Synthesis, structure-activity relationships, and pharmacokinetics

The measles virus (MeV), a member of the paramyxovirus family, is an important cause of pediatric morbidity and mortality worldwide. In an effort to provide therapeutic treatments for improved measles management, we previously identified a small, non-nucl

Therapeutic amides

Amides having formula I: STR1 wherein E, X, R2 and R3 have the meanings given in the specification, and pharmaceutically acceptable salts and pharmaceutically acceptable in vivo hydrolysable esters thereof, which are useful in the treatment of urinary incontinence. Further provided are processes for preparing the amides and pharmaceutical compositions containing them.